Literature DB >> 15765214

[Topical antibiotics in skin infections].

D Thaçi1, H Schöfer.   

Abstract

To understand the development of bacterial resistance and multi-resistance following treatment with topical and systemic antibiotics is important for dermatologists. Furthermore the sensitization potential and toxicity of antibiotics applied to large skin areas must be considered. The advantage of many topical antibiotics is evident; extremely high concentrations can be achieved in the infected skin usually without any systemic side effects. When an antibiotic is used both systemically and topically, indications should be weighed carefully for topical use, in order to reduce the likelihood of sensitization to an potential systemic agent. Continuous monitoring of the resistance profile of important bacteria is also desirable, in order to preserve the utility of important "reserve antibiotics". In this review the most important topical antibiotics used in Germany are evaluated with regards to efficacy and safety profile.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15765214     DOI: 10.1007/s00105-005-0935-4

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  25 in total

1.  Fusidic acid resistance in Staphylococcus aureus isolates.

Authors:  Erwin M Brown; Paul Thomas
Journal:  Lancet       Date:  2002-03-02       Impact factor: 79.321

Review 2.  Topical antibacterials.

Authors:  W Winkelman; D Gratton
Journal:  Clin Dermatol       Date:  1989 Jul-Sep       Impact factor: 3.541

3.  Evaluation of cutaneous reactivity to recently marketed dermatologic products.

Authors:  M V Shelanski; S B Phillips; C E Potts
Journal:  Int J Dermatol       Date:  1996-02       Impact factor: 2.736

4.  The role of topical agents in the healing of full-thickness wounds.

Authors:  M A Watcher; R G Wheeland
Journal:  J Dermatol Surg Oncol       Date:  1989-11

Review 5.  The clinical development of mupirocin.

Authors:  K A Pappa
Journal:  J Am Acad Dermatol       Date:  1990-05       Impact factor: 11.527

6.  Bacitracin-induced anaphylaxis.

Authors:  M A Vale; A Connolly; A M Epstein; M R Vale
Journal:  Arch Dermatol       Date:  1978-05

Review 7.  Clinical relevance of resistance to fusidic acid in Staphylococcus aureus.

Authors:  D C Shanson
Journal:  J Antimicrob Chemother       Date:  1990-02       Impact factor: 5.790

8.  Randomized, placebo-controlled, double-blind trial to evaluate the efficacy of mupirocin for eradicating carriage of methicillin-resistant Staphylococcus aureus.

Authors:  S Harbarth; S Dharan; N Liassine; P Herrault; R Auckenthaler; D Pittet
Journal:  Antimicrob Agents Chemother       Date:  1999-06       Impact factor: 5.191

Review 9.  Fusidic acid in dermatology.

Authors:  J D Wilkinson
Journal:  Br J Dermatol       Date:  1998-12       Impact factor: 9.302

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.